Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

InMed Pharmaceuticals Inc. buy Traumtanz

Start price
€259.05
09.10.17 / 50%
Target price
€412.50
12.10.17
Performance (%)
-4.78%
End price
€246.68
12.10.17
Summary
This prediction ended on 12.10.17 with a price of €246.68. With a performance of -4.78%, the BUY prediction by Traumtanz finished with a loss. Traumtanz has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
InMed Pharmaceuticals Inc. -15.441% -15.441% -81.117% -99.607%
iShares Core DAX® -0.258% 0.299% 15.648% 15.944%
iShares Nasdaq 100 2.964% 4.660% 32.001% 57.194%
iShares Nikkei 225® 1.217% -2.160% 6.668% 4.285%
iShares S&P 500 1.732% 2.807% 25.596% 48.530%

Comments by Traumtanz for this prediction

In the thread Inmed Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -4.78%
Target price 0.500
Change
Ends at 12.10.17

Inmed

https://www.inmedpharma.com/


Cannabinoid-Produkte sind schwer im Kommen...THC freies CBD - Öl zB oder auch Tees....hier wird geforscht....spekulativ und sehr long !  der Verlust schrumpft...ohne Gewähr!

Prediction Buy
Perf. (%) -4.78%
Target price 0.500
Change
Ends at 12.10.17

(Stop Loss Kurs erreicht)

Stopped prediction by Traumtanz for InMed Pharmaceuticals Inc.

buy
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€427.35
10.07.18
€825.00
25.07.18
-12.74%
25.07.18